Filing Flows › Abeona Therapeutics (ABEO) › Next earnings date
Abeona Therapeutics (ABEO) earnings on Nov 11, 2026: what to expect
Abeona Therapeutics (ABEO) is expected to report earnings on Nov 11, 2026 (estimated), in 3 days, for the quarter ending Sep 30, 2026. Analysts expect EPS of −$0.17 (−$0.25 to −$0.05, 4 estimates) on revenue of $14.8M, against −$0.11 a year ago. It beat the EPS estimate in 75% of the quarters on record; Filing Flows' model gives it a 71% chance of beating next time.
What to watch
Last quarter (Q2 2026) the lines that make up revenue grew like this; the report shows whether the trend holds:
Filing Flows' own estimate from the SEC figures — the same quarter last year times recent growth — is EPS −$0.11, against the analysts' −$0.17.
The last report
Abeona Therapeutics reported revenue of $11.4M for the second quarter 2026 (28× Y/Y), net loss $20.2M. How it makes money → · Every quarter →
Abeona Therapeutics' latest quarter
Abeona Therapeutics, Q2 2026: revenue $11.4M (28× year over year), operating margin -120.0%, net loss $20.2M, operating cash flow −$17.5M. The chart follows the revenue to costs, profit and cash.
Questions
When does ABEO report earnings?
Abeona Therapeutics is expected to report on Nov 11, 2026 (estimated).
What are analysts expecting from Abeona Therapeutics?
EPS of −$0.17 and revenue of $14.8M for the quarter.
Does Abeona Therapeutics usually beat earnings?
It beat the consensus EPS estimate in 75% of the quarters on record.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.